Bioniz Therapeutics, Inc. — Form D
Bioniz Therapeutics, Inc. of IRVINE, CA, a company, filed a Form D exempt-offering notice with the SEC on 2015-12-30. The offering totals $15.0M, of which $3.6M was reported sold. Industry: Biotechnology.
Offering
- Filed: 2015-12-30
- Form: D
- Accession: 0001662388-15-000001
- Industry: Biotechnology
- Exemptions: 06b
- Total offering: $15.0M
- Amount sold: $3.6M
- Remaining: $11.4M
- Investors: 5
- Date of first sale: 2015-12-17
- Security types: equity
- Revenue range: Decline to Disclose
- SEC file number: 021-254158
Issuer
- Name: Bioniz Therapeutics, Inc.
- CIK: 0001662388
- Entity type: Corporation
- Jurisdiction: DELAWARE
- Incorporated: 2015
- Address: 5 MASON, IRVINE, CA, 92618
- Phone: 949-273-6000
Officers, directors & promoters (11)
| Name | Role | Location |
|---|
| Ilan Zipkin | Director | OAKLAND, CA |
| Graham EI Cooper | Director | Irvine, CA |
| Paul EI Frohna | Executive Officer | Irvine, CA |
| Michael EI Martin | Director | Irvine, CA |
| Nazli Azimi | Director | Irvine, CA |
| Nazli Azimi | Executive Officer | Irvine, CA |
| David EI Pyott | Director | Irvine, CA |
| Joe Kiani | Director | Irvine, CA |
| Fredrik EI Wiklund | Executive Officer | Irvine, CA |
| Kleanthis Xanthopoulos | Director | Carlsbad, CA |
| David Pyott | Director | San Jose, CA |
Other filings by this issuer (5)
More